Results 131 to 140 of about 59,308 (237)

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, Volume 104, Issue 5, Page e478-e490, August 2026.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

How Preferences and Reality on Where We Die Unfold: A Four‐Country Longitudinal Qualitative Study (EOLinPLACE)

open access: yesHealth Expectations, Volume 29, Issue 4, August 2026.
ABSTRACT Context While there is a growing body of evidence on end‐of‐life (EOL) care preferences such as place of death, research remains limited in key areas. This includes gaps in understanding preferred and actual places of EOL care and death (dying places), potential shifts of preferences over time, and their (non‐)alignment with reality.
Sifra Hannah van de Beek   +11 more
wiley   +1 more source

A Concept Analysis of Expertise Associated With Practicing Clinical Nurses in Hospital Settings

open access: yesJournal of Advanced Nursing, Volume 82, Issue 8, Page 7803-7814, August 2026.
ABSTRACT Aim Analyse the concept of expertise among practicing clinical nurses in hospital settings. Background The generational loss of expert clinical nurses was exacerbated globally by the novel coronavirus. This ongoing loss combined with the increased complexity of hospitalised patients has prompted an urgent need to understand expertise among ...
Jonathan D. Hecht   +4 more
wiley   +1 more source

Hospital at Home in 10 years—Here, borrow my binoculars

open access: yesJournal of Internal Medicine, Volume 300, Issue 2, Page 153-163, August 2026.
Abstract Hospital in the Home (HAH) refers to the delivery of acute hospital care to patients at home, or in their usual place of care, including nursing homes. HAH is an acute hospital substitution service—it delivers medical, nursing and allied health staff, skills, interventions and treatments, technologies and supervision usually found in hospitals
Michael Montalto
wiley   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, Volume 32, Issue 26, 11 July 2026.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

ACKR1/Duffy‐null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 1977-1990, July 2026.
Abstract Clozapine is licenced for treatment‐resistant schizophrenia and psychosis in Parkinson's disease. In the United Kingdom, there is a mandatory requirement for absolute neutrophil count (ANC) and white blood cell count (WBC) monitoring to safeguard against agranulocytosis.
Stephen Murtough   +29 more
wiley   +1 more source

First Reported Case of Fulminant Weil's Disease in South Khorasan, Eastern Iran: Diagnostic Challenges in a Non‐Endemic Region and Implications for Military Deployment

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Weil's disease should be considered even in non‐endemic regions when compatible clinical findings are accompanied by relevant exposure history. This case is epidemiologically notable as the first documented report from South Khorasan Province, highlighting the diagnostic challenges of leptospirosis in non‐endemic settings and the potential ...
Zohreh Azarkar   +3 more
wiley   +1 more source

Hemoglobin glycation index and mortality risk in severe community-acquired pneumonia: a retrospective study. [PDF]

open access: yesJ Thorac Dis
Jiang J   +9 more
europepmc   +1 more source

Echocardiographic Probability of Pulmonary Hypertension, Cardiac Structural Alterations and All‐Cause Mortality in Maintenance Hemodialysis Patients: A Single‐Center Retrospective Cohort Study With Competing Risk Analysis

open access: yesClinical Cardiology, Volume 49, Issue 7, July 2026.
Using a Fine‑Gray competing risk model accounting for renal transplantation, pulmonary hypertension probability, age, and right ventricular diameter independently predicted mortality in maintenance hemodialysis patients. Risk profiles differed by vascular access, supporting individualized cardiovascular risk stratification.
Jingwen Zhou, Zhenhua Yang, Dongmei Huo
wiley   +1 more source

3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR−/− Mice

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
3′‐SL intervention in HCD‐fed LDLR−/− mice reduces atherosclerosis, improves metabolic parameters, and suppresses inflammation. Multi‐omics integration shows that 3′‐SL remodels gut microbiota (↓ Firmicutes/Bacteroidota, ↑ Akkermansia), alters colonic metabolites and gene expression (Kng1, Ccl2, Il2ra, C6), and coordinates the gut‐immune‐cardiovascular
Yingying Zhuang   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy